Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2015 Sep 24;6:214. doi: 10.3389/fphar.2015.00214

Corrigendum: Impact of kinase activating and inactivating patient mutations on binary PKA interactions

Ruth Röck 1, Johanna E Mayrhofer 1, Verena Bachmann 1, Eduard Stefan 1,*
PMCID: PMC4585161  PMID: 26441667

Reason for Corrigendum:

There was a mistake in the figure legend for Figure 5 as published. The correct version of the figure legend (Figure 5B) appears below. The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.

Figure 5. Impact of RIa mutations and cAMP elevation on PKA type I complexes. … (B) Following indicated modifications of RIa-F[1] sequences, combinations of wild type and mutant Rluc PCA tagged PKA subunits have been subjected to Rluc PCA measurements. The effect of isoproterenol (1 μM, 10 min; 48 h transient PCA reporter expression) on PKA complex formation has been determined (at least n = 3 independent experiments, ±SEM).

The original article was updated.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES